Horizon Pharma plc Named No. 1 Biopharma Company to Work for by Great Place to Work® and FORTUNE
April 12 2018 - 4:30PM
- Company also awarded “Best Places
to Work in Chicago” and “10 Best Places to Work for Women” by
Crain’s Chicago Business -
Horizon Pharma plc (NASDAQ:HZNP) today announced it has been
selected as the number one place to work by Great Place to Work®
and FORTUNE Magazine on its "Best Workplaces in Health Care &
Biopharma" list. The company has also been awarded a 2018
“Best Places to Work in Chicago” designation by Crain’s Chicago
Business, as well as named to their “10 Best Places to Work for
Women” list.
"It is a truly great honor to be recognized at the national
level as the number one company to work for in biopharma," said
Timothy P. Walbert, chairman, president and chief executive
officer, Horizon Pharma plc. "We are also very excited to
receive recognition as a proud and inclusive employer in
Chicagoland. At Horizon, we believe that when we help
employees live up to their potential, we help patients live up to
theirs. For all of us, working at Horizon isn’t just a job,
we take it personally. Our teams are inspired to do more
because we know we’re part of something bigger.”
The Best Workplaces in Health Care & Biopharma ranking
considers input from more than 95,000 employees in the health care
and biotechnology and pharmaceutical sectors. Great Place to
Work, a research and consulting firm, evaluated more than 50
elements of team members’ experiences on the job. These
included employee pride in the organization’s community impact,
belief that their works makes a difference and feeling their work
has special meaning.
The Crain's Chicago Business 2018 "Best Places to Work in
Chicago" designation is based on surveys conducted by Best
Companies Group. The firm surveyed Chicago-area businesses
and employees about everything from their workplace to benefits to
company culture. This year, more than 8,800 Chicago-area
employees participated.
About Horizon Pharma plcHorizon
Pharma plc is focused on researching, developing and
commercializing innovative medicines that address unmet treatment
needs for rare and rheumatic diseases. By fostering a growing
pipeline of medicines in development and exploring all potential
uses for currently marketed medicines, we strive to make a powerful
difference for patients, their caregivers and physicians. For
us, it’s personal: by living up to our own potential, we are
helping others live up to theirs. For more information,
please visit www.horizonpharma.com, follow
us @HZNPplc on Twitter or like us on Facebook.
About the Best Workplaces in Health Care &
BiopharmaGreat Place to Work based its ranking on a
data-driven methodology applied to anonymous Trust Index™ survey
responses from more than 95,000 employees at Great Place to
Work-Certified organizations in Financial Services & Insurance.
To learn more about Great Place to Work Certification and
recognition on Best Workplaces lists published with FORTUNE, visit
Greatplacetowork.com.
About Great Place to Work Great Place to Work
is the global authority on high-trust, high-performance workplace
cultures. Through its certification programs, Great Place to
Work recognizes outstanding workplace cultures and produces the
annual Fortune "100 Best Companies to Work For®" and Great Place to
Work Best Workplaces lists for Millennials, Women, Diversity, Small
& Medium Companies, industries and, internationally, countries
and regions. Through its culture consulting services,
Great Place to Work helps clients create great workplaces that
outpace peers on key business metrics like revenue growth,
profitability, retention and stock
performance. Learn more at
Greatplacetowork.com and on LinkedIn, Twitter, Facebook and
Instagram.
Contacts:Geoffrey CurtisSenior Vice President,
Corporate Affairs and Chief Communications
Officermedia@horizonpharma.com
Ireland Media Contact: Ray Gordon Gordon MRM
ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024